82 related articles for article (PubMed ID: 26397139)
21. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
Kogai T; Taki K; Brent GA
Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
[TBL] [Abstract][Full Text] [Related]
22. Sodium iodide symporter: its role in nuclear medicine.
Chung JK
J Nucl Med; 2002 Sep; 43(9):1188-200. PubMed ID: 12215558
[TBL] [Abstract][Full Text] [Related]
23. Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin.
Lakshmanan A; Scarberry D; Green JA; Zhang X; Selmi-Ruby S; Jhiang SM
Oncotarget; 2015 Oct; 6(31):31792-804. PubMed ID: 26397139
[TBL] [Abstract][Full Text] [Related]
24. High iodine concentration attenuates RET/PTC3 oncogene activation in thyroid follicular cells.
Fiore AP; Fuziwara CS; Kimura ET
Thyroid; 2009 Nov; 19(11):1249-56. PubMed ID: 19725779
[TBL] [Abstract][Full Text] [Related]
25. MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner.
Vadysirisack DD; Venkateswaran A; Zhang Z; Jhiang SM
Endocr Relat Cancer; 2007 Jun; 14(2):421-32. PubMed ID: 17639055
[TBL] [Abstract][Full Text] [Related]
26. Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells.
Liu YY; Zhang X; Ringel MD; Jhiang SM
Endocr Relat Cancer; 2012 Jun; 19(3):291-304. PubMed ID: 22355179
[TBL] [Abstract][Full Text] [Related]
27. microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.
Lakshmanan A; Wojcicka A; Kotlarek M; Zhang X; Jazdzewski K; Jhiang SM
Endocr Relat Cancer; 2015 Feb; 22(1):11-21. PubMed ID: 25404690
[TBL] [Abstract][Full Text] [Related]
28. Apigenin inhibits pancreatic stellate cell activity in pancreatitis.
Mrazek AA; Porro LJ; Bhatia V; Falzon M; Spratt H; Zhou J; Chao C; Hellmich MR
J Surg Res; 2015 Jun; 196(1):8-16. PubMed ID: 25799526
[TBL] [Abstract][Full Text] [Related]
29. Redifferentiation of iodine-refractory BRAF V600E-mutant metastatic papillary thyroid cancer with dabrafenib.
Rothenberg SM; McFadden DG; Palmer EL; Daniels GH; Wirth LJ
Clin Cancer Res; 2015 Mar; 21(5):1028-35. PubMed ID: 25549723
[TBL] [Abstract][Full Text] [Related]
30. Anoctamin-1/TMEM16A is the major apical iodide channel of the thyrocyte.
Twyffels L; Strickaert A; Virreira M; Massart C; Van Sande J; Wauquier C; Beauwens R; Dumont JE; Galietta LJ; Boom A; Kruys V
Am J Physiol Cell Physiol; 2014 Dec; 307(12):C1102-12. PubMed ID: 25298423
[TBL] [Abstract][Full Text] [Related]
31. Modulation of sodium iodide symporter in thyroid cancer.
Lakshmanan A; Scarberry D; Shen DH; Jhiang SM
Horm Cancer; 2014 Dec; 5(6):363-73. PubMed ID: 25234361
[TBL] [Abstract][Full Text] [Related]
32. Anoctamin 1 is apically expressed on thyroid follicular cells and contributes to ATP- and calcium-activated iodide efflux.
Iosco C; Cosentino C; Sirna L; Romano R; Cursano S; Mongia A; Pompeo G; di Bernardo J; Ceccarelli C; Tallini G; Rhoden KJ
Cell Physiol Biochem; 2014; 34(3):966-80. PubMed ID: 25201006
[TBL] [Abstract][Full Text] [Related]
33. The Effect of Tanespimycin (17-AAG) on Radioiodine Accumulation in Sodium-Iodide Symporter Expressing Cells.
Yu KH; Youn H; Song MG; Lee DS; Chung JK
Nucl Med Mol Imaging; 2012 Dec; 46(4):239-46. PubMed ID: 24900070
[TBL] [Abstract][Full Text] [Related]
34. Apigenin in combination with Akt inhibition significantly enhances thyrotropin-stimulated radioiodide accumulation in thyroid cells.
Lakshmanan A; Doseff AI; Ringel MD; Saji M; Rousset B; Zhang X; Jhiang SM
Thyroid; 2014 May; 24(5):878-87. PubMed ID: 24400871
[TBL] [Abstract][Full Text] [Related]
35. Overcoming acquired BRAF inhibitor resistance in melanoma via targeted inhibition of Hsp90 with ganetespib.
Acquaviva J; Smith DL; Jimenez JP; Zhang C; Sequeira M; He S; Sang J; Bates RC; Proia DA
Mol Cancer Ther; 2014 Feb; 13(2):353-63. PubMed ID: 24398428
[TBL] [Abstract][Full Text] [Related]
36. Apigenin inhibits TGF-β1 induced fibroblast-to-myofibroblast transition in human lung fibroblast populations.
Wójcik KA; Skoda M; Koczurkiewicz P; Sanak M; Czyż J; Michalik M
Pharmacol Rep; 2013; 65(1):164-72. PubMed ID: 23563034
[TBL] [Abstract][Full Text] [Related]
37. Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.
Ho AL; Grewal RK; Leboeuf R; Sherman EJ; Pfister DG; Deandreis D; Pentlow KS; Zanzonico PB; Haque S; Gavane S; Ghossein RA; Ricarte-Filho JC; Domínguez JM; Shen R; Tuttle RM; Larson SM; Fagin JA
N Engl J Med; 2013 Feb; 368(7):623-32. PubMed ID: 23406027
[TBL] [Abstract][Full Text] [Related]
38. Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism.
Mirzoeva S; Franzen CA; Pelling JC
Mol Carcinog; 2014 Aug; 53(8):598-609. PubMed ID: 23359392
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
